Cargando…

Erratum: Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma

Detalles Bibliográficos
Autor principal: Frontiers Production Office
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107049/
https://www.ncbi.nlm.nih.gov/pubmed/37077813
http://dx.doi.org/10.3389/fphar.2023.1188062
_version_ 1785026523637481472
author Frontiers Production Office,
author_facet Frontiers Production Office,
author_sort Frontiers Production Office,
collection PubMed
description
format Online
Article
Text
id pubmed-10107049
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101070492023-04-18 Erratum: Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma Frontiers Production Office, Front Pharmacol Pharmacology Frontiers Media S.A. 2023-04-03 /pmc/articles/PMC10107049/ /pubmed/37077813 http://dx.doi.org/10.3389/fphar.2023.1188062 Text en Copyright © 2023 Frontiers Production Office. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Frontiers Production Office,
Erratum: Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma
title Erratum: Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma
title_full Erratum: Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma
title_fullStr Erratum: Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma
title_full_unstemmed Erratum: Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma
title_short Erratum: Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma
title_sort erratum: drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107049/
https://www.ncbi.nlm.nih.gov/pubmed/37077813
http://dx.doi.org/10.3389/fphar.2023.1188062
work_keys_str_mv AT frontiersproductionoffice erratumdrugresistancemechanismofkinaseinhibitorsinthetreatmentofhepatocellularcarcinoma